Association of the peroxisome proliferator-activated receptor γ gene with type 2 diabetes mellitus varies by physical activity among non-Hispanic whites from Colorado

Metabolism: Clinical and Experimental

Volumn 56, Issue 3, 2007, Pages 388-393

  Nelson, Tracy L ^a,b   Fingerlin, Tasha E ^b   Moss, Laurie K ^b   Barmada, M Michael ^c   Ferrell, Robert E ^c   Norris, Jill M ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; DIETARY INTAKE; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PEDIGREE; PHYSICAL ACTIVITY; PPARGAMMA GENE; PRIORITY JOURNAL; RECEPTOR GENE; UNITED STATES;

ADULT; AGED; ALLELES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MIDDLE AGED; PPAR GAMMA;

EID: 33846838454     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.10.022     Document Type: Article

References (37)

1. Centers for Disease Control (CDC). National diabetes surveillance system (2004), US Department of Health and Human Services. www/cdc.gov/diabeted/statistics/index.htm
2. Elbein S. The genetics of human noninsulin-dependent (type 2) diabetes mellitus. J Nutr 127 (1997) 1891S-1896S
3. Bartsocas C., and Leslie R.D. Genetics of diabetes mellitus. Am J Med Genet 115 (2002) 1-3
4. Auwerx J. PPAR gamma, the ultimate thrifty gene. Diabetologia 42 (1999) 1033-1049
5. Kliewer S., Xu H.E., Lambert M.H., and Willson T.M. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 56 (2001) 239-263
6. Hara K., Tobe K., Okada T., Kadowaki H., Akanuma Y., Ito C., et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes. Diabetologia 45 (2002) 740-743
7. Evans D., de Heer J., Hagemann C., Wendt D., Wolf A., Beisiegel U., et al. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPARgamma) gene and type 2 diabetes. Exp Clin Endocrinol Diabetes 109 (2001) 151-154
8. Andruliontye L., Zacharova J., Chiasson J.L., Laasko M., and STOP-NIDDM Study Group. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia 47 (2004) 2176-2184
9. Stumvoll M., Stefan N., Fritsche A., Madaus A., Tschritter O., Koch M., et al. Interaction effects between common polymorphisms in PPARgamma2 and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity. J Mol Med 80 (2002) 33-38
10. Lindi V., Uusitupa M.I.J., Lindstrom J., Louheranta A., Eriksson J.G., Valle T.T., et al. Association of the Pro12Ala polymorphism in the PPAR-γ gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish diabetes prevention study. Diabetes 51 (2002) 2581-2586
11. Kao W., Coresh J., Shuldiner A.R., Boerwinkle E., Bray M.S., and Brancati F.L. Pro12Ala of the peroxisome proliferator-activated receptor-2 gene is associated with lower serum insulin levels in nonobese African Americans. Diabetes 52 (2003) 1568-1572
12. Ek J., Anderson G., Urhammer S.A., Hansen L., Carstensen B., Borch-Johnsen K., et al. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant Caucasians. Diabetologia 44 (2001) 1170-1176
13. Li S., Chen W., Srinivasan S.R., Boerwinkle E., and Berenson G.S. The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study. Diabetes 52 (2003) 1265-1269
14. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., et al. The common PPAR gamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 (2000) 76-80
15. van Dam R.M., Willett W.C., Rimm E.B., Stampfer M.J., and Hu F.B. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25 (2002) 417-424
16. Manco M., Calvani M., and Mingrone G. Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab 6 (2004) 402-413
17. Pan X., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20 (1997) 537-544
18. Luan J., Browne P.O., Harding A.H., Halsall D.J., O'Rahilly S., Krishna V.K., et al. Evidence for gene-nutrient interaction at the PPAR γ locus. Diabetes 50 (2001) 686-689
19. Franks P., Luan J., Browne P.O., Harding A.H., Rahilly S.O., Chatterjee V.K.K., et al. Does peroxisome proliferator-activated receptor γ geneotype (Pro12Ala) modify the association of physical activity and dietary fat with fasting insulin level?. Metabolism 53 (2004) 11-16
20. Damcott C., Moffett S.P., Feingold E., Barmada M.M., Marshal J.A., Hamman R.F., et al. Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males. Metabolism 53 (2004) 303-309
21. O'Connell J.R., and Weeks D.E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63 (1998) 259-266
22. Kriska A., Knowler W.C., LaPorte R.E., Drash A.L., Wing R.R., Blair S.N., et al. Development of a questionnaire to examine the relationship of physical activity and diabetes in Pima Indians. Diabetes Care 13 (1990) 401-411
23. Lynch J., Helmrich S.P., Lakka T.A., Kaplan G.A., Cohen R.D., Salonen R., et al. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med 156 (1996) 307-314
24. Block G., Hartman A.M., Dresser C.M., Carroll M.D., Gannon J., and Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124 (1986) 453-469
25. Block G., Woods M., Potosky A., and Clifford D. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 43 (1990) 1327-1335
26. Mayer-Davis E.J., Vitolins M.Z., Carmichael S.L., Hemphill S., Tsaroucha G., Rushing J., et al. Validity and reproducibility of a food frequency interview in a multi-cultural epidemiology study. Ann Epidemiol 9 (1999) 314-324
27. Horvath S., Xu X., and Laird N.M. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9 (2001) 301-306
28. Spielman R., McGinnis R.E., and Ewens W.J. Transmission test for linkage disequillibrium: the insulin gene region and insulin dependent diabetes mellitus (IDDM). Am J Hum Genet 52 (1993) 506-516
29. Rabinowitz D., and Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 50 (2000) 211-223
30. Lake S.L., Blacker D., and Laird N.M. Family-based tests of association in the presence of linkage. Am J Hum Genet 67 (2000) 1515-1525
31. Cole S., Mitchell B.D., Hsueh W.C., Pineda P., Beamer P.A., Shuldiner A.R., et al. The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-γ2) is associated with measures of obesity in Mexican Americans. Int J Obes 24 (2000) 522-524
32. Robitaille J., Despres J.P., Perusse L., and Vohl M.C. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin Genet 63 (2003) 109-116
33. WHO. Obesity: preventing and managing the global epidemic (1998), WHO Division of Noncommunicable Diseases, Geneva
34. Pisabarro R.E., Sanguinetti C., Stoll M., and Prendez D. High incidence of type 2 diabetes in peroxisome proliferator-activated receptor gamma2 Pro12Ala carriers exposed to a high chronic intake of trans fatty acids and saturated fatty acids. Diabetes Care 27 (2004) 2251-2252
35. Ghoussaini M., Meyre D., Lobbens S., Charpentier G., Clement K., Charles M.A., et al. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet 6 (2005) 11
36. Deeb S., Fajas L., Nemoto M., Pihlajamaki J., Mykkanen L., Kuusisto J., et al. Nature Gen. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20 (1998) 284-287
37. Moffett S., Feingold E., Barmada M.M., Damcott C.M., Marshall J.A., Hamman R.F., et al. The C161→T polymorphism in peroxisome proliferator-activated receptor gamma, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic white women: evidence for another functional variant in peroxisome proliferator-activated receptor gamma. Metabolism 54 (2005) 1552-1556